Clinical Trial Update: Vasoactive Intestinal Peptide in COPD

View source ↗

Summary

This completed clinical trial evaluated vasoactive intestinal peptide in patients with chronic obstructive pulmonary disease, including those with pulmonary hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Vasoactive intestinal peptide (vasoactive intestinal peptide)

Snippet

Sponsor: Medical University of Vienna | Conditions: COPD, Pulmonary Hypertension | Status: COMPLETED